Twist Bioscience Corporation

TWST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-59.3M
Depreciation & Amortization $5.0M
Depreciation
Amortization
Stock-Based Compensation $1.9M
Net Cash from Operating Activities $-51.3M
Investing Activities
Capital Expenditures $6.6M
Business Acquisitions
Net Cash from Investing Activities $-10.0M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $63.8M
Net Change in Cash $2.5M
Free Cash Flow $-57.9M
← Newer Page 2 of 2 Older →